|American Medical Systems||Minnesota, Minnetonka, United States|
|Aschendorff NEXT||Germany, Münster, Nordrhein-Westfalen|
|Atila Venture||Bermuda, Hamilton|
|Beijing Huaxi Investment Development||Beijing, Beijing, China|
|ChemRar Ltd||Khimki, Moscow Oblast, Russia|
|CID Equity Partners||Indiana, Indianapolis, United States|
|Code Authority||Frisco, Texas, United States|
|Fujita Kanko||Japan, Tokyo|
|Guoxuan Ziben||Beijing, China, Haidian|
|Leadenhall Capital Partners||England, London, United Kingdom|
|Mabel Technologies Limited||Hefa, Hefa, Israel|
|MercadoLivre.com||Brazil, Santana de Parnaíba, São Paulo|
|Position A Partners||California, Ross, United States|
|PPL||Allentown, Pennsylvania, United States|
|Puzhi Information Technology||China, Japan, Kagoshima Prefecture|
|Velo Fund||British Columbia, Canada, Vancouver|
|$3M||29 Aug 2017||Jakarta, Jakarta Raya, Indonesia|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.